From Surf Wiki (app.surf) — the open knowledge base
Mapp Biopharmaceutical
Mapp Biopharmaceutical is an American pharmaceutical company founded in 2003 by Larry Zeitlin and Kevin Whaley. Mapp Biopharmaceutical is based in San Diego, California. It is responsible for the research and development of ZMapp, a drug which is still under development and comprises three humanized monoclonal antibodies used as a treatment for Ebola virus disease. The drug was first tested in humans during the 2014 West Africa Ebola virus outbreak.
Rendering article…
This content may have been generated or modified by AI, and may be sourced from third parties. CloudSurf Software LLC makes no warranties as to its accuracy, completeness, or reliability, and accepts no liability for it. Always verify important information against primary sources.
Report